{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:23:10Z","timestamp":1787725390028,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10157-026-02885-y","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:59:20Z","timestamp":1779764360000},"page":"1315-1323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetic peripheral neuropathy as an independent predictor of renal function decline in type 2 diabetes: a propensity score-matched retrospective cohort study using DPN-Check\u00ae"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8143-0082","authenticated-orcid":false,"given":"Hiroyuki","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Chiaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzuko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Antoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifusa","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizuko","family":"Yukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"2885_CR1","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jdiacomp.2012.04.011","volume":"26","author":"H Ito","year":"2012","unstructured":"Ito H, Oshikiri K, Mifune M, et al. The usefulness of the revised classification for chronic kidney disease by the KDIGO for determining the frequency of diabetic micro- and macroangiopathies in Japanese patients with type 2 diabetes mellitus. J Diabetes Complications. 2012;26:286\u201390.","journal-title":"J Diabetes Complications"},{"key":"2885_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-025-02175-1","volume":"10","author":"Y Yang","year":"2025","unstructured":"Yang Y, Zhao B, Wang Y, et al. Diabetic neuropathy: cutting-edge research and future directions. Signal Transduct Target Ther. 2025;10:132.","journal-title":"Signal Transduct Target Ther"},{"key":"2885_CR3","doi-asserted-by":"publisher","first-page":"e002480","DOI":"10.1136\/bmjdrc-2021-002480","volume":"9","author":"M Chowdhury","year":"2021","unstructured":"Chowdhury M, Nevitt S, Eleftheriadou A, et al. Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis. BMJ Open Diabetes Res Care. 2021;9:e002480.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2885_CR4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00125-014-3211-2","volume":"57","author":"AA Tahrani","year":"2014","unstructured":"Tahrani AA, Dubb K, Raymond NT, et al. Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study. Diabetologia. 2014;57:1249\u201356.","journal-title":"Diabetologia"},{"key":"2885_CR5","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2337\/db23-0247","volume":"73","author":"Y Tang","year":"2024","unstructured":"Tang Y, Ang L, Jaiswal M, et al. Cardiovascular autonomic neuropathy and risk of kidney function decline in type 1 and type 2 diabetes: findings from the PERL and ACCORD cohorts. Diabetes. 2024;73:751\u201362.","journal-title":"Diabetes"},{"key":"2885_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/jdi.13625","volume":"13","author":"T Muramatsu","year":"2022","unstructured":"Muramatsu T, Takahashi M, Kakinuma R, et al. Decline in renal function associated with cardiovascular autonomic neuropathy positively coordinated with proteinuria in patients with type 2 diabetes. J Diabetes Investig. 2022;13:102\u201311.","journal-title":"J Diabetes Investig"},{"key":"2885_CR7","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.2147\/IJGM.S363474","volume":"15","author":"J Yang","year":"2022","unstructured":"Yang J, Jiang S. Development and validation of a model that predicts the risk of diabetic nephropathy in type 2 diabetes mellitus patients: a cross-sectional study. Int J Gen Med. 2022;15:5089\u2013101.","journal-title":"Int J Gen Med"},{"key":"2885_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12902-016-0147-1","volume":"16","author":"QA Altaf","year":"2016","unstructured":"Altaf QA, Sadiqi H, Piya MK, Tahrani AA. Foot insensitivity is associated with renal function decline in patients with type 2 diabetes: a cohort study. BMC Endocr Disord. 2016;16:64.","journal-title":"BMC Endocr Disord"},{"key":"2885_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/jdi.14348","volume":"16","author":"T Muramatsu","year":"2025","unstructured":"Muramatsu T, Yamamuro D, Kushiyama A, Kikuchi T. Deterioration in ankle reflex is associated with a reduced estimated glomerular filtration rate in patients with type 2 diabetes: a retrospective observational cohort study. J Diabetes Investig. 2025;16:225\u201335.","journal-title":"J Diabetes Investig"},{"key":"2885_CR10","doi-asserted-by":"publisher","first-page":"671257","DOI":"10.3389\/fendo.2021.671257","volume":"12","author":"J Carmichael","year":"2021","unstructured":"Carmichael J, Fadavi H, Ishibashi F, Shore AC, Tavakoli M. Advances in screening, early diagnosis and accurate staging of diabetic neuropathy. Front Endocrinol (Lausanne). 2021;12:671257.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2885_CR11","doi-asserted-by":"publisher","first-page":"e86515","DOI":"10.1371\/journal.pone.0086515","volume":"9","author":"JA Lee","year":"2014","unstructured":"Lee JA, Halpern EM, Lovblom LE, Yeung E, Bril V, Perkins BA. Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy. PLoS ONE. 2014;9:e86515.","journal-title":"PLoS ONE"},{"key":"2885_CR12","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/jdi.13007","volume":"10","author":"Y Shibata","year":"2019","unstructured":"Shibata Y, Himeno T, Kamiya T, et al. Validity and reliability of a point-of-care nerve conduction device in diabetes patients. J Diabetes Investig. 2019;10:1291\u20138.","journal-title":"J Diabetes Investig"},{"key":"2885_CR13","unstructured":"Nakamura J. Ministry of Health, Labour and Welfare Scientific Research Grant (Comprehensive Research on Cardiovascular and Lifestyle-related Diseases including Diabetes). Final Report: Establishment of diagnostic criteria and management of diabetic neuropathy and diabetic foot lesions. 2021. https:\/\/mhlw-grants.niph.go.jp\/system\/files\/download_pdf\/2020\/202009045A.pdf [in Japanese]. Accessed 29 Mar 2026."},{"issue":"Suppl 1","key":"2885_CR14","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/j.diabres.2007.01.053","volume":"77","author":"H Yasuda","year":"2007","unstructured":"Yasuda H, Sanada M, Kitada K, et al. Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. Diabetes Res Clin Pract. 2007;77(Suppl 1):S178\u201383.","journal-title":"Diabetes Res Clin Pract"},{"key":"2885_CR15","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"2885_CR16","first-page":"9","volume":"63","author":"K Ito","year":"2022","unstructured":"Ito K, Ito H, Nagaiwa Y, et al. Utility of DPNCheck\u00ae, a point-of-care nerve conduction device, in the risk assessment of diabetic foot lesions by nurses. J Japanese Diabetes Soc. 2022;63:9\u201317. [in Japanese, abstract in English].","journal-title":"J Japanese Diabetes Soc"},{"key":"2885_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/qjmed\/hcz249","volume":"113","author":"YR Lai","year":"2020","unstructured":"Lai YR, Cheng BC, Huang CC, et al. Correlation between kidney and peripheral nerve functions in type 2 diabetes. QJM. 2020;113:173\u201380.","journal-title":"QJM"},{"key":"2885_CR18","doi-asserted-by":"publisher","first-page":"1497750","DOI":"10.3389\/fmed.2024.1497750","volume":"11","author":"M Ebrahimi","year":"2025","unstructured":"Ebrahimi M, Ahmadieh H, Rezaei Kanavi M, et al. Shared signaling pathways and comprehensive therapeutic approaches among diabetes complications. Front Med (Lausanne). 2025;11:1497750.","journal-title":"Front Med (Lausanne)"},{"key":"2885_CR19","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/dme.13630","volume":"35","author":"O Binns-Hall","year":"2018","unstructured":"Binns-Hall O, Selvarajah D, Sanger D, et al. One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot. Diabet Med. 2018;35:887\u201394.","journal-title":"Diabet Med"},{"key":"2885_CR20","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383:1436\u201346.","journal-title":"N Engl J Med"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02885-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02885-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02885-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:46:34Z","timestamp":1787723194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02885-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2885"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02885-y","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H Ito has received lecture fees from Eli Lilly Japan, Mitsubishi Tanabe Pharma Corporation, Sumitomo Pharma, Novo Nordisk Pharma, Nippon Boehringer Ingelheim, Sanofi, Astellas Pharma, Kowa Company, Taisho Pharmaceutical, Daiichi Sankyo Company, Novartis Pharma, Takeda Pharmaceutical Company, MSD, Terumo Corporation, Mochida Pharmaceuticals, Teijin Pharma, Kissei Pharmaceuticals, Sanwa Kagaku Kenkyusho, AstraZeneca, Kyowa Kirin, Otsuka Pharmaceutical, Bayer Yakuhin, EA Pharma, Ono Pharmaceutical, Viatris, Abbott, Sawai Pharmaceutical, and Vantive Japan. S Matsumoto has received lecture fees from Eli Lilly Japan, Novo Nordisk Pharma, Astellas Pharma, Kyowa Kirin, and AstraZeneca. H Inoue has received lecture fees from Nippon Boehringer Ingelheim, Sumitomo Pharma, Novartis Pharma, AstraZeneca, and Mochida Pharmaceuticals. S Antoku has received lecture fees from Nippon Boehringer Ingelheim, Kyowa Kirin, Sanofi, Taisho Pharmaceutical, Daiichi Sankyo Company, Novo Nordisk Pharma, Novartis Pharma, AstraZeneca, and Otsuka Pharmaceutical. T Mori has received lecture fees from Novartis Pharma and Kyowa Kirin. M Yamamoto, Y Kuwahara, C I, M Matsushita, T Yamasaki, S Miura, K Nishio, A Takaki, and C Yukawa have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Edogawa Hospital (IRB approval number 2025-29; approval date: August 6, 2025) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was registered with the UMIN Clinical Trials Registry (UMIN000059867).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Edogawa Hospital approved the study protocol and waived the requirement for written informed consent, as data were anonymized for this retrospective analysis (IRB approval number: 2025-29; approval date: August 6, 2025).","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}